Q2 2026 13F filing
Updated 28 days ago73 disclosed positions worth $213.8M
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | K KLAC KLA CORPORATION | $53.8M | 178.5K | 25.18% | — |
| 2 | C CELG-RI BRISTOL-MYERS SQUIBB CO | $17.1M | 297.2K | 8.01% | — |
| 3 | L LRCX LAM RESEARCH CORPORATION | $15.2M | 35.0K | 7.09% | — |
| 4 | S SLDB SOLID BIOSCIENCES INC | $6.7M | 666.2K | 3.11% | — |
| 5 | N NTLA INTELLIA THERAPEUTICS INC | $6.5M | 385.4K | 3.05% | — |
| 6 | B BDSX BIODESIX INC | $6.5M | 286.8K | 3.02% | — |
| 7 | S STOK STOKE THERAPEUTICS INC | $5.8M | 178.1K | 2.73% | — |
| 8 | O OVV OVINTIV INC | $5.7M | 107.5K | 2.65% | — |
| 9 | N NKTR NEKTAR THERAPEUTICS | $5.7M | 81.0K | 2.64% | — |
| 10 | C CORT CORCEPT THERAPEUTICS INC | $5M | 57.2K | 2.33% | — |
| 11 | N NBIX NEUROCRINE BIOSCIENCES INC | $4.6M | 27.2K | 2.14% | — |
| 12 | P PRTA PROTHENA CORP PLC | $4.4M | 449.0K | 2.06% | — |
| 13 | A ACAD ACADIA PHARMACEUTICALS INC | $4.3M | 171.0K | 2.02% | — |
| 14 | P PB PROTAGONIST THERAPEUTICS INC | $4.3M | 35.0K | 2.01% | — |
| 15 | ? N/A COMPASS THERAPEUTICS INC | $3.7M | 1.68M | 1.72% | — |
| 16 | R RLMD RELMADA THERAPEUTICS INC | $2.8M | 408.1K | 1.32% | — |
| 17 | A ALKS ALKERMES PLC | $2.6M | 50.0K | 1.23% | — |
| 18 | H HALO HALOZYME THERAPEUTICS INC | $2.6M | 33.3K | 1.22% | — |
| 19 | C CLDX CELLDEX THERAPEUTICS INC | $2.6M | 69.9K | 1.22% | — |
| 20 | C CYTK CYTOKINETICS INC | $2.6M | 30.0K | 1.20% | — |
| 21 | O OLMA OLEMA PHARMACEUTICALS INC | $2.5M | 199.0K | 1.16% | — |
| 22 | V VERA VERA THERAPEUTICS INC | $2.5M | 57.8K | 1.16% | — |
| 23 | U UTHR UNITED THERAPEUTICS CORP | $2.4M | 4.5K | 1.14% | — |
| 24 | Z ZBIO ZENAS BIOPHARMA INC | $2.4M | 93.6K | 1.11% | — |
| 25 | Q QURE UNIQURE NV | $2.3M | 50.7K | 1.09% | — |
| 26 | P PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC | $2.3M | 1.35M | 1.06% | — |
| 27 | A AAVXF ABIVAX SA | $2.3M | 17.0K | 1.06% | — |
| 28 | V VIR VIR BIOTECHNOLOGY INC | $2.2M | 220.0K | 1.05% | — |
| 29 | B BIIB BIOGEN INC | $1.9M | 9.0K | 0.91% | — |
| 30 | E EQT EQT CORPORATION | $1.8M | 34.6K | 0.86% | — |
| 31 | ? N/A BIOAGE LABS INC | $1.7M | 69.0K | 0.79% | — |
| 32 | T TVTX TRAVERE THERAPEUTICS INC | $1.6M | 29.0K | 0.77% | — |
| 33 | Q QDEL QUIDELORTHO CORP | $1.6M | 89.4K | 0.73% | — |
| 34 | A AXSM AXSOME THERAPEUTICS INC | $1.5M | 6.0K | 0.69% | — |
| 35 | F FHTX FOGHORN THERAPEUTICS INC | $1.4M | 281.9K | 0.64% | — |
| 36 | B BCYC BICYCLE THERAPEUTICS PLC | $1.3M | 313.6K | 0.62% | — |
| 37 | G GPCR STRUCTURE THERAPEUTICS INC | $1.3M | 24.0K | 0.60% | — |
| 38 | X XENE XENON PHARMACEUTICALS INC | $1.3M | 21.0K | 0.59% | — |
| 39 | N NONOF NOVO NORDISK A/S | $1.2M | 24.0K | 0.54% | — |
| 40 | F FCX FREEPORT-MCMORAN CL-B | $1.1M | 18.0K | 0.53% | — |
| 41 | I IMNM IMMUNOME INC | $1.1M | 50.0K | 0.50% | — |
| 42 | P PHVS PHARVARIS N V | $1M | 29.8K | 0.48% | — |
| 43 | H HROW HARROW HEALTH INC | $1M | 24.0K | 0.48% | — |
| 44 | A ADAG ADAGENE INC | $1M | 240.0K | 0.47% | — |
| 45 | D DFTX DEFINIUM THERAPEUTICS INC | $941K | 20.0K | 0.44% | — |
| 46 | S SLNCF SILENCE THERAPEUTICS PLC | $782K | 71.2K | 0.37% | — |
| 47 | B BBIO BRIDGEBIO PHARMA INC | $651K | 8.7K | 0.30% | — |
| 48 | F FDMT 4D MOLECULAR THERAPEUTICS INC | $645K | 48.5K | 0.30% | — |
| 49 | U URGN UROGEN PHARMA LTD | $607K | 16.5K | 0.28% | — |
| 50 | P PHAT PHATHOM PHARMACEUTICALS INC | $597K | 55.0K | 0.28% | — |